ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching.

Hillel P Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.